Information Journal Paper
APA:
Copy. (2019). High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial. HELICOBACTER, 24(4), 0-0. SID. https://sid.ir/paper/698492/en
Vancouver:
Copy. High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial. HELICOBACTER[Internet]. 2019;24(4):0-0. Available from: https://sid.ir/paper/698492/en
IEEE:
Copy, “High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial,” HELICOBACTER, vol. 24, no. 4, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/698492/en